PortfoliosLab logoPortfoliosLab logo
LENZ vs. CSWC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LENZ vs. CSWC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LENZ Therapeutics Inc (LENZ) and Capital Southwest Corporation (CSWC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LENZ achieves a -56.19% return, which is significantly lower than CSWC's 9.39% return.


LENZ

1D
-1.68%
1M
-24.46%
YTD
-56.19%
6M
-74.96%
1Y
-76.45%
3Y*
-10.86%
5Y*
10Y*

CSWC

1D
-1.82%
1M
-3.08%
YTD
9.39%
6M
12.32%
1Y
27.28%
3Y*
20.78%
5Y*
8.63%
10Y*
17.04%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LENZ vs. CSWC - Yearly Performance Comparison


2026 (YTD)20252024202320222021
LENZ
LENZ Therapeutics Inc
-56.19%-44.58%230.71%-21.08%-73.29%-32.81%
CSWC
Capital Southwest Corporation
9.39%14.28%2.14%56.10%-24.63%10.34%

Correlation

The correlation between LENZ and CSWC is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jun 28, 2021

0.20

The correlation between LENZ and CSWC shifts across timeframes, from 0.09 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

LENZ:

$219.78M

CSWC:

$1.45B

EPS

LENZ:

-$3.66

CSWC:

$1.76

PS Ratio

LENZ:

9.94

CSWC:

6.70

PB Ratio

LENZ:

0.89

CSWC:

1.43

Total Revenue (TTM)

LENZ:

$20.99M

CSWC:

$222.04M

Gross Profit (TTM)

LENZ:

$19.37M

CSWC:

$172.70M

EBITDA (TTM)

LENZ:

-$116.01M

CSWC:

$142.78M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LENZ vs. CSWC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LENZ
LENZ Risk / Return Rank: 66
Overall Rank
LENZ Sharpe Ratio Rank: 66
Sharpe Ratio Rank
LENZ Sortino Ratio Rank: 44
Sortino Ratio Rank
LENZ Omega Ratio Rank: 55
Omega Ratio Rank
LENZ Calmar Ratio Rank: 77
Calmar Ratio Rank
LENZ Martin Ratio Rank: 88
Martin Ratio Rank

CSWC
CSWC Risk / Return Rank: 7676
Overall Rank
CSWC Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
CSWC Sortino Ratio Rank: 7777
Sortino Ratio Rank
CSWC Omega Ratio Rank: 7373
Omega Ratio Rank
CSWC Calmar Ratio Rank: 7171
Calmar Ratio Rank
CSWC Martin Ratio Rank: 7777
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LENZ vs. CSWC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for LENZ Therapeutics Inc (LENZ) and Capital Southwest Corporation (CSWC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LENZCSWCDifference
Sharpe ratioReturn per unit of total volatility

-2.39

Sortino ratioReturn per unit of downside risk

-3.82

Omega ratioGain probability vs. loss probability

0.79

1.26

-0.47

Calmar ratioReturn relative to maximum drawdown

-0.89

1.74

-2.63

Martin ratioReturn relative to average drawdown

-1.41

5.62

-7.03

LENZ vs. CSWC - Sharpe Ratio Comparison

The current LENZ Sharpe Ratio is -0.94, which is lower than the CSWC Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of LENZ and CSWC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LENZCSWCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.94

1.45

-2.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.38

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.62

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.46

0.39

-0.85

Drawdowns

LENZ vs. CSWC - Drawdown Comparison

The maximum LENZ drawdown since its inception was -93.98%, which is greater than CSWC's maximum drawdown of -68.33%. Use the drawdown chart below to compare losses from any high point for LENZ and CSWC.


Loading charts...

Drawdown Indicators


LENZCSWCDifference

Max Drawdown

Largest peak-to-trough decline

-93.98%

-68.33%

-25.65%

Max Drawdown (1Y)

Largest decline over 1 year

-86.44%

-15.75%

-70.69%

Max Drawdown (3Y)

Largest decline over 3 years

-86.44%

-27.74%

-58.70%

Max Drawdown (5Y)

Largest decline over 5 years

-33.66%

Max Drawdown (10Y)

Largest decline over 10 years

-61.15%

Current Drawdown

Current decline from peak

-93.15%

-3.88%

-89.27%

Average Drawdown

Average peak-to-trough decline

-78.62%

-18.36%

-60.26%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.23%

4.86%

+49.37%

Volatility

LENZ vs. CSWC - Volatility Comparison

LENZ Therapeutics Inc (LENZ) has a higher volatility of 30.21% compared to Capital Southwest Corporation (CSWC) at 5.22%. This indicates that LENZ's price experiences larger fluctuations and is considered to be riskier than CSWC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LENZCSWCDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.21%

5.22%

+24.99%

Volatility (6M)

Calculated over the trailing 6-month period

62.94%

13.99%

+48.95%

Volatility (1Y)

Calculated over the trailing 1-year period

81.33%

18.91%

+62.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.28%

22.66%

+54.62%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.28%

27.40%

+49.88%

Dividends

LENZ vs. CSWC - Dividend Comparison

LENZ has not paid dividends to shareholders, while CSWC's dividend yield for the trailing twelve months is around 12.72%.


PositionTTM20252024202320222021202020192018201720162015
CSWC
Capital Southwest Corporation
12.72%11.56%11.59%10.21%12.46%10.13%11.49%13.07%10.77%7.01%2.35%216.86%
LENZ
LENZ Therapeutics Inc
0.00%0.00%28.54%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

LENZ vs. CSWC - Financials Comparison

This section allows you to compare key financial metrics between LENZ Therapeutics Inc and Capital Southwest Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M60.00M20222023202420252026
1.90M
54.00M
(LENZ) Total Revenue
(CSWC) Total Revenue
Values in USD except per share items

Frequently Asked Questions


LENZ and CSWC have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LENZ has higher volatility (30.21%) compared to CSWC (5.22%). In terms of maximum drawdown, LENZ dropped -93.98% vs CSWC's -68.33%.

CSWC currently has the higher Sharpe Ratio (1.45 vs -0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LENZ and CSWC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer